Toggle light / dark theme

BioViva at Journey to 100

Gearing up for clinical trials.


Liz discusses how we can overcome the limits on human health and lifespan; elaborating on BioViva’s role as a translational engine to provide access to cutting-edge therapies for those most in need.

http://journey100.org | Journey to 100 is a world-exclusive conference exploring ideas for a new and sustainable approach to lifelong health. The day kick starts a 10-year project that aims to make Guernsey the first community in the world to break through the 100-year life expectancy barrier.

Co-curated by the Dandelion Foundation and James Maskell, founder of Evolution of Medicine, and hosted by Dr Rangan Chatterjee, the BBC’s Doctor in the House, Journey to 100 hosted 20 leading global health, lifestyle and longevity experts.

Researchers Produce World’s First Probiotic Beer

As if anyone needed any excuse to drink more beer, a team of researchers have managed to produce an alcoholic beverage that also contains probiotics. In a novel breakthrough, they claim that the beer could help improve gut health and immunity, though the science is still out on that last one.

There are plenty of dairy-based probiotics, but currently there are no beers that also contain probiotics, mainly because beer contains something known as hop acids, which limit the growth and survival of potential probiotics. This spurred the researchers at the National University of Singapore to see if they could manage it.

They succeeded in developing a sour beer that can support the probiotic strain known as Lactobacillus paracasei L26. This particular probiotic is already found in the human gut, and there is some evidence that it might be able to regulate the immune system.

How Will We Stop Hackers From Invading Our Brains Once We’re Cyborgs?

Rapid developments in brain-machine interfacing and neuroprosthetics are revolutionizing the way we treat paralyzed people, but the same technologies could eventually be put to more generalized use—a development that’ll turn many of us into veritable cyborgs. Before we get to that point, however, we’ll need to make sure these neural devices are safe, secure, and as hacker-proof as possible.

In anticipation of our cyborg future, researchers from the Wyss Center for Bio and Neuroengineering in Geneva Switzerland have published a new Policy Forum paper in Science titled, “Help, hope, and hype: Ethical dimensions of neuroprosthetics.” The intent of the authors is to raise awareness of this new breed of neurotechnologies, and the various ways they can be abused. Importantly, the researchers come up with some ways to mitigate potential problems before they arise.

Bioquark Inc. and Lakmus LLC Announce Research Collaboration to Study Novel Biopharmaceuticals for Healthy Longevity Enhancement

Philadelphia, PA, USA / Moscow, Russia — Bioquark, Inc., (www.bioquark.com) a life sciences company focused on the development of novel bio-products for regeneration, disease reversion, and healthy aging, and Moscow based, Lakmus LLC, a diversified investment company with business interests in pharmacies, restaurants, and real estate, announced a multi-disciplinary research collaboration with the FSBI Zakusov Institute of Pharmacology, Russian Academy of Medical Sciences (http://www.academpharm.ru/), and the Pavlov Institute of Physiology of the Russian Academy of Sciences (http://www.infran.ru/), to jointly study the pharmacotherapeutic longevity enhancement properties of its combinatorial regenerative biologic candidates.

“We are very excited about this continued collaboration with Lakmus,” said Ira S. Pastor, CEO, Bioquark Inc. “The disciplined development of our combinatorial biologic candidates (Bioquantines) for healthy longevity enhancement, represents another important step in our continued evolution as a company focused on a broad range of therapeutic products and services in the regenerative healthcare space.”

Throughout the 20th century, natural products formed the basis for a majority of all pharmaceuticals, biologics, and consumer healthcare products used by patients around the globe, generating trillions of dollars of wealth. However, many scientists believe we have only touched the surface with what the natural world, and its range of organisms, which from a health and wellness perspective are much further advanced than human beings, has to teach us.

The integration of a complex set of newer research disciplines, including interkingdom signaling, semiochemical communication, and evolutionary biology, as well as significant recent activity in the areas of the microbiome, are highlighting a myriad of new ways that non-human bio-products can affect the human genome for positive transitions in health and wellness dynamics.

“Bioquark has spent several years studying the natural ability of many species to turn back biological time in order to maintain health, fitness, and survival, developing a broad understanding of the combinatorial biochemical approaches they use to control nested hierarchies of disease (i.e. gene, cell, tissue, organism, environment),” said Dr. Sergei Paylian, Founder, CSO, and President, Bioquark Inc. “This research initiative is one more step in the path in allowing humans to recapture these capabilities to effectively counter our unfortunate progression into aging, disease and degeneration.”

About Bioquark, Inc.

Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.

Biotech startup Aortica raising $4M to develop personalized blood vessel stents for aortic aneurysms

The aorta is an important blood vessel, to say the least. It’s the body’s main artery, carrying blood from the heart up to the head and down to the other major organs. That’s why aortic aneurysms, or weak spots in the aorta, are so concerning: if they break, the extreme blood loss is often fatal.

Seattle-area biotech startup Aortica is working on a personalized approach to treating aortic aneurysms, specifically complex abdominal aortic aneurysms, which are more tricky to treat. The company has closed just over $1 million out of a $4 million round of insider funding to further develop the treatment, and Aortica CEO and founder Thomas Douthitt told GeekWire the company has commitments to finish the full $4 million round.

Help Us Crowdfund the Cure for Aging — Be a Lifespan Hero: Join Us!

Introducing Lifespan Heroes our new campaign.


Here at Lifespan.io we are funding research to help extend healthy human lifespan, supporting nonprofits and companies working to overcome age-related diseases. By becoming a “Lifespan Hero” you can join us in this humanitarian and necessary effort — http://www.lifespan.io/heroes — and help us end age-related diseases for good.

In this video Lifespan.io / LEAF President Keith Comito explains the work Lifespan.io has done thus far in funding research, educating the public, and building a grass roots movement in support of healthy human lifespan, as well as the work that can be done in the future with the support of heroes willing to stand up and fight against the diseases of aging, like Alzheimer’s, heart disease, and cancer, by addressing their shared root causes.

Together we can do this; please join us.

This video is presented by LEAF. Please support our work to overcome the diseases of aging: http://lifespan.io/hero

Rejuvenation is good for you

If you are not sure why you should support rejuvenation research, or know people who aren’t, this article explains why rejuvenation would be good for you as an individual.


The reasons why rejuvenation would be good for any given individual should be bleeding obvious. However, you’d be surprised how often people think it all boils down to ‘You’d live forever!’—which by the way is not granted and can be a bit of a controversial concept. The real reasons why rejuvenation would be good for you as an individual are the following.

The elderly of today aren’t exactly famous for their good health, nor for their ability to go about their lives easily and without help in even the simplest tasks. Old people have weaker bodies, weaker immune systems, are prey to a number of horrible diseases and chronic pain, and cannot take care of themselves with the same ease as they did when they were young. Pay attention next time you go downtown. You’ll see elderly people walking slowly and with difficulty, perhaps with the aid of a walker or a cane. They can’t hear well and they can’t see well. Climbing the stairs for them feels like more climbing a mountain. A young person can shake off the flu after a few days of discomfort; an old person may well die of the complications of it, because their weak immune system did not do a very good job. This is, in a nutshell, why young people can take care of themselves and old people end up in hospices or have to be watched over by their families.